tiprankstipranks
Trending News
More News >
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (HK:1276)
:1276
Hong Kong Market
1276
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H
RESEARCH TOOLSreports

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (1276) Stock Forecast & Price Target

Compare
0 Followers
See the Price Targets and Ratings of:

1276 Financial Forecast

1276 Earnings Forecast

Next quarter’s earnings estimate for 1276 is HK$0.15 with a range of HK$0.15 to HK$0.15. The previous quarter’s EPS was HK$0.32. 1276 beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.13% of the time in the same period. In the last calendar year 1276 has Preformed in-line its overall industry.
Next quarter’s earnings estimate for 1276 is HK$0.15 with a range of HK$0.15 to HK$0.15. The previous quarter’s EPS was HK$0.32. 1276 beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.13% of the time in the same period. In the last calendar year 1276 has Preformed in-line its overall industry.

1276 Sales Forecast

Next quarter’s sales forecast for 1276 is HK$7.28B with a range of HK$7.28B to HK$7.28B. The previous quarter’s sales results were HK$7.64B. 1276 beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 47.44% of the time in the same period. In the last calendar year 1276 has Outperformed its overall industry.
Next quarter’s sales forecast for 1276 is HK$7.28B with a range of HK$7.28B to HK$7.28B. The previous quarter’s sales results were HK$7.64B. 1276 beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 47.44% of the time in the same period. In the last calendar year 1276 has Outperformed its overall industry.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

1276 Analyst Recommendation Trends

Currently, no data available
Please return soon. This page is being updated.
Each month's total comprises the sum of three months' worth of ratings.

1276 Stock Forecast FAQ

What is HK:1276’s average 12-month price target, according to analysts?
Currently, no data Available
What is HK:1276’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for HK:1276, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H a Buy, Sell or Hold?
      Currently, no data Available
      What is Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H’s share price target?
      Currently, no data Available
      What do analysts say about Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H?
      To buy shares of HK:1276, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis